Arvinas (ARVN) Soars 14% as Investors Cheer Pipeline Reset and Jefferies Update
Arvinas (NASDAQ: ARVN) jumped in double digits on November 18, 2025 amid a focused pipeline reset, FDA momentum for vepdegestrant and attention at the Jefferies London Healthcare Conference. ARVN stock pops on November 18, 2025 Arvinas shares are in rally mode this Tuesday. By mid‑afternoon U.S. trading, ARVN is up more than 14% on the day, with intraday prices hovering around the low‑$13 level and turnover far above normal. Quiver Quantitative+1 Pre‑market data set the tone: ChartMill flagged Arvinas as one of the most active names before the bell, with premarket quotes around $13.60, up more than 23% from the